Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options
{{output}}
There are no US FDA-approved therapies for the management of frontotemporal dementia (FTD). Evidence-based medicine that would support a FDA indication for the treatment of FTD requires large-scale, randomized, double-blind, placebo-controlled trials that do n... ...
